Vipera Berus Venom Market
Vipera Berus Venom Market
The market for Vipera Berus Venom was estimated at $797.40 million in 2024; it is anticipated to increase to $1.49 billion by 2030, with projections indicating growth to around $2.51 billion by 2035.
Global Vipera Berus Venom Market Outlook
Revenue, 2024 (US$M)
$797M
Forecast, 2034 (US$B)
$2.26B
CAGR, 2024 - 2034
11.0%
Market Key Insights
- The Vipera Berus Venom market is projected to grow from $797.4 million in 2024 to $2.26 billion in 2034. This represents a CAGR of 11%, reflecting rising demand across Medicinal Use, Cosmetic and Biomedical Research.
- Venomex Company, Exotic Venom International, Serpents Kiss Ltd are among the leading players in this market, shaping its competitive landscape.
- U.S. and Germany are the top markets within the Vipera Berus Venom market and are expected to observe the growth CAGR of 8.0% to 11.6% between 2024 and 2030.
- Emerging markets including Brazil, South Korea and United Arab Emirates are expected to observe highest growth with CAGR ranging between 10.6% to 13.8%.
- Transition like Emergence in Cosmetics is expected to add $204.2 million to the Vipera Berus Venom market growth by 2030
- The Vipera Berus Venom market is set to add $1.5 billion between 2024 and 2034, with manufacturer targeting Cosmetics & Biomedical Research End-Use Applications projected to gain a larger market share.
- With Rising demand in pharmaceuticals, and Technological advancements in venom extraction, Vipera Berus Venom market to expand 184% between 2024 and 2034.
Opportunities in the Vipera Berus Venom
Vipera Berous Venom is considered a substance with great therapeutic possibilities being explored for various health conditions like chronic pain and cancer among others, through ongoing research and development efforts aimed at discovering new uses for this venomous compound.
Growth Opportunities in North America and Europe
North America Outlook
Europe Outlook
Market Dynamics and Supply Chain
Driver: Rising Demand in Pharmaceuticals, and Increasing Scope in Cosmetics Industry
Restraint: Regulatory Hurdles
Opportunity: Innovation in Cosmeceutical Industry and Strategic Collaborations for Antivenom Production
Challenge: Limited Public Awareness
Supply Chain Landscape
Harvesting
Vipera Labs
Croatian Institute of Immunology
Processing
Sigma-Aldrich
Thermo Fisher Scientific
Distribution
Merck KGaA
GlaxoSmithKline Plc
End-Use
Pharmaceutical
Health & Wellness industry
Harvesting
Vipera Labs
Croatian Institute of Immunology
Processing
Sigma-Aldrich
Thermo Fisher Scientific
Distribution
Merck KGaA
GlaxoSmithKline Plc
End-Use
Pharmaceutical
Health & Wellness industry